Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor
NCT: NCT06367686 · COMPLETED
Brief Summary
The study is an open, prospective, single center clinical observational pilot investigation. The aim is to compare the carbon dioxide values measured by the IscAlert sensor, which is inserted in proximity to the nasal mucosa. The study wants to investigate if the nasal mucosa application and measurements are feasible, what kind of possible complications such a measurement can cause, and if the measurements can be a surrogate marker for systemic carbon dioxide values.
Frequently Asked Questions
What is Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor?
Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor is a clinical trial registered under NCT06367686. Current status: COMPLETED.
What is the status of NCT06367686?
The current status of NCT06367686 (Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor) is: COMPLETED.
When did Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor start?
Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor started on 2025-01-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.